Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Suxibuzone

Suxibuzone

Suxibuzone structure

Suxibuzone 

structure
  • CAS No:

    27470-51-5

  • Formula:

    C24H26N2O6

  • Chemical Name:

    Suxibuzone

  • Synonyms:

    Butanedioic acid,1-[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester;Succinic acid,monoester with 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione;Butanedioic acid,mono[(4-butyl-3,5-dioxo-1,2-diphenyl-4-pyrazolidinyl)methyl] ester;3,5-Pyrazolidinedione,4-butyl-4-(hydroxymethyl)-1,2-diphenyl-,hydrogen succinate (ester);4-Hydroxymethylbutazolidine hemisuccinate;Suxibuzone;AE 17;Flogos;Solurol;Calibene;Danilon;Suxibutazone

  • Categories:

    Analytical Chemistry  >  Standard

Description

Suxibuzone is a drug used for joint and muscular pain, is a prodrug of the non steroidal anti inflammatory drug Phenylbutazone.


Suxibuzone is a pyrazolidine that is phenylbutazone which is substituted by a 3-carboxypropanoylmethyl group at the 4-position. Suxibuzone is a prodrug for phenylbutazone and is commonly used as an anti-inflammatory drug in horses. It has a role as a prodrug, a non-steroidal anti-inflammatory drug, an antirheumatic drug, a non-narcotic analgesic and a peripheral nervous system drug. It is a member of pyrazolidines, a monocarboxylic acid and a hemisuccinate.

Suxibuzone Basic Attributes

438.47

438.47

248-477-6

86TDZ5WP2B

757866

DTXSID6021296

M - Musculo-skeletal system

2933990090

Characteristics

104.22000

3.69600

1.265g/cm3

126-127 °C

590.1ºC at 760 mmHg

310.7ºC

1.579

Practically insoluble in water, freely soluble in acetone, soluble in ethanol (96 per cent), practically insoluble in cyclohexane.

9.05E-15mmHg at 25°C

LD50 orally in mice: 5.683 micromol/kg (Esteve, 1973)

199.3 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

3

20/21/22

36

WM9640000

Xn

P280

H302-H312-H332

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|Aggregated GHS information provided by 39 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)

1,2-diphenyl-4-n-butyl-4-hydroxymethyl-3,5-dioxopyrazolidine hemisuccinate

Suxibuzone Use and Manufacturing

Uses

analgesic, antipyretic, antiinflammatory

Pharmaceuticals

Computed Properties

Molecular Weight:438.5
XLogP3:3.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:11
Exact Mass:438.17908655
Monoisotopic Mass:438.17908655
Topological Polar Surface Area:104
Heavy Atom Count:32
Complexity:661
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Suxibuzone

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.